<http://schema.org/description>
"Showing that patients can switch from expensive biologics to biosimilars could prove a windfall for drug companies and help bring down health care costs."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.statnews.com/pharmalot/2016/02/23/biosimilars-switching/>